Literature DB >> 24876443

Effect of algorithm aggressiveness on the performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System.

Daniel A Finan1, Thomas W McCann2, Kathleen Rhein2, Eyal Dassau3, Marc D Breton4, Stephen D Patek4, Henry Anhalt2, Boris P Kovatchev4, Francis J Doyle3, Stacey M Anderson5, Howard Zisser3, Ramakrishna Venugopalan2.   

Abstract

The Hypoglycemia-Hyperglycemia Minimizer (HHM) System aims to mitigate glucose excursions by preemptively modulating insulin delivery based on continuous glucose monitor (CGM) measurements. The "aggressiveness factor" is a key parameter in the HHM System algorithm, affecting how readily the system adjusts insulin infusion in response to changing CGM levels. Twenty adults with type 1 diabetes were studied in closed-loop in a clinical research center for approximately 26 hours. This analysis focused on the effect of the aggressiveness factor on the insulin dosing characteristics of the algorithm and, to a lesser extent, on the glucose control results observed. As the aggressiveness factor increased from conservative to medium to aggressive: the maximum observed insulin dose delivered by the algorithm—which is designed to give doses that are corrective in nature every 5 minutes—increased (1.00 vs 1.15 vs 2.20 U, respectively); tendency to adhere to the subject's nominal basal dose decreased (61.9% vs 56.6% vs 53.4%); and readiness to decrease insulin below basal also increased (18.4% vs 19.4% vs 25.2%). Glucose analyses by both CGM and Yellow Springs Instruments (YSI) indicated that the aggressive setting of the algorithm resulted in the least time spent at levels >180 mg/dL, and the most time spent between 70-180 mg/dL. There was no severe hyperglycemia, diabetic ketoacidosis, or severe hypoglycemia for any of the aggressiveness values investigated. These analyses underscore the importance of investigating the sensitivity of the HHM System to its key parameters, such as the aggressiveness factor, to guide future development decisions.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  aggressiveness factor; algorithm; artificial pancreas; closed loop; tuning parameter

Mesh:

Substances:

Year:  2014        PMID: 24876443      PMCID: PMC4764230          DOI: 10.1177/1932296814534589

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  9 in total

1.  Closed-Loop Control Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System in a Feasibility Study.

Authors:  Daniel A Finan; Thomas W McCann; Linda Mackowiak; Eyal Dassau; Stephen D Patek; Boris P Kovatchev; Francis J Doyle; Howard Zisser; Henry Anhalt; Ramakrishna Venugopalan
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

2.  Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia.

Authors:  Marc Breton; Anne Farret; Daniela Bruttomesso; Stacey Anderson; Lalo Magni; Stephen Patek; Chiara Dalla Man; Jerome Place; Susan Demartini; Simone Del Favero; Chiara Toffanin; Colleen Hughes-Karvetski; Eyal Dassau; Howard Zisser; Francis J Doyle; Giuseppe De Nicolao; Angelo Avogaro; Claudio Cobelli; Eric Renard; Boris Kovatchev
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.461

3.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Authors:  Roman Hovorka; Janet M Allen; Daniela Elleri; Ludovic J Chassin; Julie Harris; Dongyuan Xing; Craig Kollman; Tomas Hovorka; Anne Mette F Larsen; Marianna Nodale; Alessandra De Palma; Malgorzata E Wilinska; Carlo L Acerini; David B Dunger
Journal:  Lancet       Date:  2010-02-04       Impact factor: 79.321

4.  Nocturnal glucose control with an artificial pancreas at a diabetes camp.

Authors:  Moshe Phillip; Tadej Battelino; Eran Atlas; Olga Kordonouri; Natasa Bratina; Shahar Miller; Torben Biester; Magdalena Avbelj Stefanija; Ido Muller; Revital Nimri; Thomas Danne
Journal:  N Engl J Med       Date:  2013-02-28       Impact factor: 91.245

5.  Modular artificial beta-cell system: a prototype for clinical research.

Authors:  Eyal Dassau; Howard Zisser; Cesar C Palerm; Bruce A Buckingham; Lois Jovanovic; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2008-09

6.  Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes.

Authors:  Aaron J Kowalski
Journal:  Diabetes Technol Ther       Date:  2009-06       Impact factor: 6.118

7.  Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.

Authors:  Boris P Kovatchev; Eric Renard; Claudio Cobelli; Howard C Zisser; Patrick Keith-Hynes; Stacey M Anderson; Sue A Brown; Daniel R Chernavvsky; Marc D Breton; Anne Farret; Marie-Josée Pelletier; Jérôme Place; Daniela Bruttomesso; Simone Del Favero; Roberto Visentin; Alessio Filippi; Rachele Scotton; Angelo Avogaro; Francis J Doyle
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

8.  Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas.

Authors:  Steven J Russell; Firas H El-Khatib; David M Nathan; Kendra L Magyar; John Jiang; Edward R Damiano
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

9.  Clinical evaluation of a personalized artificial pancreas.

Authors:  Eyal Dassau; Howard Zisser; Rebecca A Harvey; Matthew W Percival; Benyamin Grosman; Wendy Bevier; Eran Atlas; Shahar Miller; Revital Nimri; Lois Jovanovic; Francis J Doyle
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

  9 in total
  5 in total

Review 1.  Physical activity and type 1 diabetes: time for a rewire?

Authors:  Sheri R Colberg; Remmert Laan; Eyal Dassau; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2015-01-06

2.  Identification of Main Factors Explaining Glucose Dynamics During and Immediately After Moderate Exercise in Patients With Type 1 Diabetes.

Authors:  Najib Ben Brahim; Jerome Place; Eric Renard; Marc D Breton
Journal:  J Diabetes Sci Technol       Date:  2015-10-18

3.  Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.

Authors:  Daniel A Finan; Eyal Dassau; Marc D Breton; Stephen D Patek; Thomas W McCann; Boris P Kovatchev; Francis J Doyle; Brian L Levy; Ramakrishna Venugopalan
Journal:  J Diabetes Sci Technol       Date:  2015-06-30

4.  Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.

Authors:  Sunil Deshpande; Jordan E Pinsker; Stamatina Zavitsanou; Dawei Shi; Randy Tompot; Mei Mei Church; Camille Andre; Francis J Doyle; Eyal Dassau
Journal:  Diabetes Technol Ther       Date:  2018-12-14       Impact factor: 6.118

Review 5.  The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes.

Authors:  Brian L Levy; Thomas W McCann; Daniel A Finan
Journal:  Eur Endocrinol       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.